Pharmacokinetics of enrofloxacin in lactating sheep
- PMID: 12726743
- DOI: 10.1016/s0034-5288(03)00003-1
Pharmacokinetics of enrofloxacin in lactating sheep
Abstract
The pharmacokinetics of enrofloxacin (ENR) was investigated after its intravenous (iv) and intramuscular (im) administration in six healthy lactating sheep. After iv ENR injection (as a bolus), the elimination half-life (t(1/2beta)), the volume of distribution (Vd(area)), and the area under the concentration vs. time curve (AUC) were 3.30 (0.36)h, 2.91 (0.17)l/kg and 4.19 (0.18) microg h/ml, respectively. The maximum milk concentrations of ENR (C(max)), the area under the milk concentration vs. time curve (AUC(milk)) and the ratio AUC(milk)/AUC(serum) were 2.38 (0.14)microg/ml, 23.76 (2.21) microg h/ml and 5.62 (0.30), respectively. After im administration of ENR the t(1/2beta), C(max), time of C(max) (t(max)) and absolute bioavailability (F(abs)) were 3.87 (0.10)h, 0.74 (0.07) microg/ml, 0.83 (0.12)h and 75.35%, respectively. The C(max), AUC(milk) and the ratio AUC(milk)/AUC(serum) were 1.94 (0.13) microg/ml, 24.81 (2.25) microg h/ml and 8.15 (0.96), respectively.
Similar articles
-
Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.Can J Vet Res. 2001 Jan;65(1):64-7. Can J Vet Res. 2001. PMID: 11227198 Free PMC article.
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intramuscular administration of enrofloxacin in goats.Vet Res Commun. 2001 Apr;25(3):197-204. doi: 10.1023/a:1006481625615. Vet Res Commun. 2001. PMID: 11334149
-
Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep.Am J Vet Res. 2002 Jul;63(7):1012-7. doi: 10.2460/ajvr.2002.63.1012. Am J Vet Res. 2002. PMID: 12118662
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.Vet J. 2002 Jan;163(1):85-93. doi: 10.1053/tvjl.2001.0594. Vet J. 2002. PMID: 11749141
-
Toxicity induced by ciprofloxacin and enrofloxacin: oxidative stress and metabolism.Crit Rev Toxicol. 2021 Oct;51(9):754-787. doi: 10.1080/10408444.2021.2024496. Crit Rev Toxicol. 2021. PMID: 35274591 Review.
Cited by
-
Comparative Study on Pharmacokinetics of Four Long-Acting Injectable Formulations of Enrofloxacin in Pigs.Front Vet Sci. 2021 Jan 26;7:604628. doi: 10.3389/fvets.2020.604628. eCollection 2020. Front Vet Sci. 2021. PMID: 33575278 Free PMC article.
-
Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig.Drug Deliv. 2019 Dec;26(1):273-280. doi: 10.1080/10717544.2019.1580798. Drug Deliv. 2019. PMID: 30880494 Free PMC article.
-
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes.J Vet Med Sci. 2016 Mar;78(3):397-403. doi: 10.1292/jvms.15-0464. Epub 2015 Nov 20. J Vet Med Sci. 2016. PMID: 26596287 Free PMC article.
-
Antibacterial Drug Residues in Small Ruminant Edible Tissues and Milk: A Literature Review of Commonly Used Medications in Small Ruminants.Animals (Basel). 2022 Sep 28;12(19):2607. doi: 10.3390/ani12192607. Animals (Basel). 2022. PMID: 36230347 Free PMC article. Review.
-
Pharmacokinetics of sarafloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio.Fish Physiol Biochem. 2016 Feb;42(1):335-41. doi: 10.1007/s10695-015-0141-y. Epub 2015 Nov 12. Fish Physiol Biochem. 2016. PMID: 26563280
MeSH terms
Substances
LinkOut - more resources
Full Text Sources